HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.

Volume: 39, Pages: 5580 - 5580
Published: May 20, 2021
Abstract
5580Background: HER2 is an emerging prognostic and therapeutic target in uterine serous carcinoma (USC). Testing algorithms and platforms in breast and gastric cancers are well studied and...
Paper Details
Title
HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.
Published Date
May 20, 2021
Volume
39
Pages
5580 - 5580
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.